Beijing, China

Hua Sun

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Changchun Intellicrown Pharmaceutical Co., Ltd., Chinese Academy of Medical Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hua Sun. Retrieved from https://idiyas.com/inventor/hua-sun-xwpfimr6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hua Sun - Innovator in Pharmaceutical Chemistry

Introduction

Hua Sun is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on left-handed bicyclic morpholine.

Latest Patents

Hua Sun holds 1 patent for his invention titled "Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use." This invention focuses on a left-handed bicyclic morpholine and a pharmaceutically acceptable salt, along with its preparation method and applications in creating medicaments for preventing and treating liver diseases.

Career Highlights

Throughout his career, Hua Sun has worked with esteemed organizations such as the Chinese Academy of Medical Sciences and Changchun Intellicrown Pharmaceutical Co., Ltd. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Hua Sun has collaborated with notable colleagues, including Song Wu and Jinlan Zhang, contributing to various projects in the pharmaceutical sector.

Conclusion

Hua Sun's innovative contributions to pharmaceutical chemistry highlight his role as a key inventor in the field. His work continues to impact the development of treatments for liver diseases and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…